Related Experiment Video
Updated: Jul 8, 2026

Isolation of Brain-infiltrating Leukocytes
Published on: June 13, 2011
POLIOVIRUS: GUANIDINE DEPENDENCE AND LOSS OF NEUROVIRULENCE FOR MONKEYS
Abstract:
Guanidine-dependent polioviruses are obtained in vitro by subculturing Brunenders, Mahoney, and Sabin strains in the presence of increasing concentrations of guanidine. Mahoney viruses dependent on guanidine lose virulence (as indicated by paralysis) for monkeys inoculated intramuscularly or intracerebrally. Protection against virulent Mahoney viruses is induced by treatment with guanidine-dependent strains, and serum antibodies against the virulent strains are present in the treated animals
Insights
Guanidine-dependent poliovirus strains were developed in vitro. These modified viruses offer protection against virulent strains and induce protective antibodies in treated animals.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Poliovirus remains a significant public health concern.
- Developing safe and effective polio vaccines is crucial for eradication efforts.
- Understanding viral attenuation mechanisms is key to vaccine design.
Purpose of the Study:
- To generate guanidine-dependent poliovirus strains in vitro.
- To assess the virulence of guanidine-dependent strains in vivo.
- To evaluate the protective efficacy of guanidine-dependent strains against virulent poliovirus.
Main Methods:
- Subculturing of Brunenders, Mahoney, and Sabin poliovirus strains in increasing guanidine concentrations.
- Intramuscular and intracerebral inoculation of monkeys with guanidine-dependent and virulent Mahoney strains.
- Assessment of paralysis in inoculated monkeys to determine virulence.
- Evaluation of protection against virulent Mahoney virus challenge after treatment with guanidine-dependent strains.
- Measurement of serum antibodies against virulent strains in treated animals.
Main Results:
- Guanidine-dependent poliovirus strains were successfully obtained in vitro.
- Mahoney viruses dependent on guanidine exhibited reduced virulence in monkeys.
- Treatment with guanidine-dependent strains conferred protection against virulent Mahoney virus.
- Treated animals developed serum antibodies against virulent poliovirus strains.
Conclusions:
- Guanidine-dependent poliovirus strains represent a potential avenue for vaccine development.
- These modified strains demonstrate attenuation and induce protective immunity.
- Further research into guanidine-dependent polioviruses could advance polio eradication strategies.
Related Concept Videos
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Botulism
Poliomyelitis
Arboviral Encephalitis
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology

